Key Computational Biology Market Players:
- Thermo Fisher Scientific (U.S.)
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Illumina, Inc. (U.S.)
- Dassault Systèmes BIOVIA (France)
- DNAnexus (U.S.)
- Genedata AG (Switzerland)
- Schrödinger (U.S.)
- QIAGEN (Germany)
- Certara (U.S.)
- Seven Bridges Genomics (U.S.)
- Benchling (U.S.)
- Insilico Medicine (Hong Kong)
- DNASTAR (U.S.)
- Biomax Informatics AG (Germany)
- SimBioSys (U.S.)
- Cyclica (Canada)
The international market is extremely competitive, owing to the presence of notable players, including Thermo Fisher Scientific and Illumina, owing to their combined dominance in bioinformatics and sequencing. Besides, companies in Europe, such as Genedata and Dassault Systèmes, collectively specialize in AI-powered drug discovery, while U.S.-based firms, such as DNAnexus and Schrödinger, have focused on molecular modeling and cloud genomics. Meanwhile, AI collaborations, mergers and acquisitions, and cloud expansion are other tactical initiatives that are positively impacting the overall market’s growth internationally.
Here is a list of key players operating in the global market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of the computational biology market was over USD 7.2 billion.
The market size for the computational biology market is projected to reach USD 22.8 billion by the end of 2035 expanding at a CAGR of 13.7% during the forecast period i.e., between 2026-2035.
The major players in the market are Seven Bridges Genomics, Benchling, Insilico Medicine, DNASTAR, and others.
In terms of the product segment, the software segment is anticipated to garner the largest market share of 42.7% by 2035 and display lucrative growth opportunities during 2026-2035.
The market in North America is projected to hold the largest market share of 42.2% by the end of 2035 and provide more business opportunities in the future.
